Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TTPH

Tetraphase Pharmaceuticals (TTPH) Stock Price, News & Analysis

Tetraphase Pharmaceuticals logo

About Tetraphase Pharmaceuticals Stock (NASDAQ:TTPH)

Advanced Chart

Key Stats

Today's Range
$2.18
$2.27
50-Day Range
$2.20
$2.20
52-Week Range
$0.56
$8.60
Volume
282,689 shs
Average Volume
932,542 shs
Market Capitalization
$15.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TTPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tetraphase Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TTPH Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
TTPH_old Historical Data
10 Worst NASDAQ Biotech Stocks in the Third Quarter
See More Headlines

TTPH Stock Analysis - Frequently Asked Questions

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) released its quarterly earnings data on Thursday, May, 7th. The biopharmaceutical company reported ($1.31) EPS for the quarter, topping the consensus estimate of ($1.63) by $0.32. The biopharmaceutical company had revenue of $1.76 million for the quarter, compared to analyst estimates of $2.45 million. Tetraphase Pharmaceuticals had a negative net margin of 798.18% and a negative trailing twelve-month return on equity of 210.86%.

Tetraphase Pharmaceuticals shares reverse split on the morning of Friday, September 27th 2019.The 1-20 reverse split was announced on Thursday, September 26th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 26th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tetraphase Pharmaceuticals investors own include Alcoa (AA), Aurinia Pharmaceuticals (AUPH), GE Aerospace (GE), Bank of America (BAC), OPKO Health (OPK), Novavax (NVAX) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
5/07/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TTPH
CIK
1373707
Fax
N/A
Employees
119
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($22.85)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.08 million
Net Margins
-798.18%
Pretax Margin
N/A
Return on Equity
-210.86%
Return on Assets
-121.73%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
3.66
Quick Ratio
3.56

Sales & Book Value

Annual Sales
$7.38 million
Price / Sales
2.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.68 per share
Price / Book
0.33

Miscellaneous

Outstanding Shares
7,263,000
Free Float
N/A
Market Cap
$15.98 million
Optionable
Optionable
Beta
2.33
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:TTPH) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners